SLC2A1 and prostate cancer: In the latter report, apigenin-7-O-glucoside also inhibited with an IC50 value of 29.7 μg/ml47. Apigenin lowered GLUT1 expression in a nude mouse model of laryngeal carcinoma48 and in prostate cancer cells49.